569 related articles for article (PubMed ID: 8052854)
1. Inhibition of NF-kappa B by sodium salicylate and aspirin.
Kopp E; Ghosh S
Science; 1994 Aug; 265(5174):956-9. PubMed ID: 8052854
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional induction of multiple cytokines by human respiratory syncytial virus requires activation of NF-kappa B and is inhibited by sodium salicylate and aspirin.
Bitko V; Velazquez A; Yang L; Yang YC; Barik S
Virology; 1997 Jun; 232(2):369-78. PubMed ID: 9191851
[TBL] [Abstract][Full Text] [Related]
3. Both PU.1 and nuclear factor-kappa B mediate lipopolysaccharide- induced HIV-1 long terminal repeat transcription in macrophages.
Lodie TA; Reiner M; Coniglio S; Viglianti G; Fenton MJ
J Immunol; 1998 Jul; 161(1):268-76. PubMed ID: 9647233
[TBL] [Abstract][Full Text] [Related]
4. The c-rel protooncogene product represses NF-kappa B p65-mediated transcriptional activation of the long terminal repeat of type 1 human immunodeficiency virus.
Doerre S; Sista P; Sun SC; Ballard DW; Greene WC
Proc Natl Acad Sci U S A; 1993 Feb; 90(3):1023-7. PubMed ID: 8430069
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of I kappa B molecules on Tat-mediated transactivation of HIV-1 LTR.
Harhaj E; Blaney J; Millhouse S; Sun SC
Virology; 1996 Feb; 216(1):284-7. PubMed ID: 8615004
[TBL] [Abstract][Full Text] [Related]
6. Distinct transcriptional pathways of TAR-dependent and TAR-independent human immunodeficiency virus type-1 transactivation by Tat.
Yang L; Morris GF; Lockyer JM; Lu M; Wang Z; Morris CB
Virology; 1997 Aug; 235(1):48-64. PubMed ID: 9300036
[TBL] [Abstract][Full Text] [Related]
7. Insulin activates nuclear factor kappa B in mammalian cells through a Raf-1-mediated pathway.
Bertrand F; Philippe C; Antoine PJ; Baud L; Groyer A; Capeau J; Cherqui G
J Biol Chem; 1995 Oct; 270(41):24435-41. PubMed ID: 7592658
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of nuclear factor kappa B subunit p65 mRNA accumulation in lipopolysaccharide-stimulated human monocytic cells treated with sodium salicylate.
Takashiba S; Van Dyke TE; Amar S
Oral Microbiol Immunol; 1996 Dec; 11(6):420-4. PubMed ID: 9467376
[TBL] [Abstract][Full Text] [Related]
9. Salicylates inhibit I kappa B-alpha phosphorylation, endothelial-leukocyte adhesion molecule expression, and neutrophil transmigration.
Pierce JW; Read MA; Ding H; Luscinskas FW; Collins T
J Immunol; 1996 May; 156(10):3961-9. PubMed ID: 8621937
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of nuclear factor kappa B by prostaglandin A1: an effect associated with heat shock transcription factor activation.
Rossi A; Elia G; Santoro MG
Proc Natl Acad Sci U S A; 1997 Jan; 94(2):746-50. PubMed ID: 9012856
[TBL] [Abstract][Full Text] [Related]
11. The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta.
Yin MJ; Yamamoto Y; Gaynor RB
Nature; 1998 Nov; 396(6706):77-80. PubMed ID: 9817203
[TBL] [Abstract][Full Text] [Related]
12. The effect of sodium salicylate and aspirin on NF-kappa B.
Frantz B; O'Neill EA
Science; 1995 Dec; 270(5244):2017-9. PubMed ID: 8533099
[No Abstract] [Full Text] [Related]
13. Aspirin inhibits tumor cell invasiveness induced by Epstein-Barr virus latent membrane protein 1 through suppression of matrix metalloproteinase-9 expression.
Murono S; Yoshizaki T; Sato H; Takeshita H; Furukawa M; Pagano JS
Cancer Res; 2000 May; 60(9):2555-61. PubMed ID: 10811139
[TBL] [Abstract][Full Text] [Related]
14. NF-kappa B site-mediated negative regulation of the HIV-1 promoter by CCAAT/enhancer binding proteins in brain-derived cells.
Mondal D; Alam J; Prakash O
J Mol Neurosci; 1994-1995; 5(4):241-58. PubMed ID: 7577367
[TBL] [Abstract][Full Text] [Related]
15. Functionally distinct NF-kappa B binding sites in the immunoglobulin kappa and IL-2 receptor alpha chain genes.
Cross SL; Halden NF; Lenardo MJ; Leonard WJ
Science; 1989 Apr; 244(4903):466-9. PubMed ID: 2497520
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effect of E3330, a novel quinone derivative able to suppress tumor necrosis factor-alpha generation, on activation of nuclear factor-kappa B.
Goto M; Yamada K; Katayama K; Tanaka I
Mol Pharmacol; 1996 May; 49(5):860-73. PubMed ID: 8622636
[TBL] [Abstract][Full Text] [Related]
17. Stimulation of a human T-cell clone with anti-CD3 or tumor necrosis factor induces NF-kappa B translocation but not human immunodeficiency virus 1 enhancer-dependent transcription.
Hazan U; Thomas D; Alcami J; Bachelerie F; Israel N; Yssel H; Virelizier JL; Arenzana-Seisdedos F
Proc Natl Acad Sci U S A; 1990 Oct; 87(20):7861-5. PubMed ID: 2146676
[TBL] [Abstract][Full Text] [Related]
18. Regulation of I kappa B alpha and p105 in monocytes and macrophages persistently infected with human immunodeficiency virus.
McElhinny JA; MacMorran WS; Bren GD; Ten RM; Israel A; Paya CV
J Virol; 1995 Mar; 69(3):1500-9. PubMed ID: 7853483
[TBL] [Abstract][Full Text] [Related]
19. Activation of the IL-2 gene promoter by HTLV-I tax involves induction of NF-AT complexes bound to the CD28-responsive element.
Good L; Maggirwar SB; Sun SC
EMBO J; 1996 Jul; 15(14):3744-50. PubMed ID: 8670878
[TBL] [Abstract][Full Text] [Related]
20. Cyclooxygenase (COX)-2 inhibitor celecoxib abrogates TNF-induced NF-kappa B activation through inhibition of activation of I kappa B alpha kinase and Akt in human non-small cell lung carcinoma: correlation with suppression of COX-2 synthesis.
Shishodia S; Koul D; Aggarwal BB
J Immunol; 2004 Aug; 173(3):2011-22. PubMed ID: 15265936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
